jimki

Potensi Pemanfaatan Serum Mir 122-5p Sebagai Biomarker Dalam Deteksi Dini Infark Miokard Akut Pada Pasien Lanjut Usia

Authors

  • Muhammad Abi Ghoffari Siregar

    S1 Pendidikan Dokter Fakultas Kedokteran Universitas Andalas, Padang 25163, Indonesia
  • Fariz Hidayat

    S1 Pendidikan Dokter Fakultas Kedokteran Universitas Andalas, Padang 25163, Indonesia
  • Vito Rayhansyah

    S1 Pendidikan Dokter Fakultas Kedokteran Universitas Andalas, Padang 25163, Indonesia

DOI:

https://doi.org/10.53366/jimki.v10i2.529

Keywords:

Biomarker, microRNA, Acute Myocardial Infarction, Elderly, Screening

Abstract

Acute myocardial infarction is the first manifestation of CAD which is the leading cause of death worldwide. The increasing incidence is often associated with increasing age where eldery are mostly affected with this disease. Although there are several biomarkers such as troponin I and T in detecting the risk of developing AMI, it has been found that populations over 70 years have elevated troponin I levels and increased troponin T levels in non-AMI cases. Because of that, a specific biomarker that can specifically detect AMI is needed. This literature review is aimed to discuss the possibility by using miR-122-5p serum for specific biomarker in detecting AMI in eldery population. The literature search was conducted based on journal searching related to the topic such as, PubMed, Science Direct, and Google Scholar. Based on the literature research we have done and our topic, we have obtained the results as follows. Pathogenesis of AMI, the underlying mechanism of miR-122-5p in association with AMI, the specificity of miR-122-5p for AMI, and the comparison of miR-122-5p with other AMI biomarkers. From the pathogenesis of AMI, we have obtained the basis of the disease, the underlying mechanism explains the potential relation to AMI and the detection, through the specificity we can see how it may be effective as a biomarker, and the comparison may reveal it’s potential and how it compares to other biomarkers.

References

1. Eisen A, Giugliano RP, Braunwald E. Updates on acute coronary syndrome: A review. JAMA Cardiol 2016;1(6):718–30.

2. Kanuri SH, Kreutz RP. Micro RNA sequencing for myocardial infarction screening [Internet]. Elsevier Inc.; 2019. Available from: http://dx.doi.org/10.1016/B978-0-12-819178-1.00018-6

3. Zhang B, Li B, Qin F, Bai F, Sun C, Liu Q. Expression of serum microRNA-155 and its clinical importance in patients with heart failure after myocardial infarction. J Int Med Res 2019;47(12):6294–302.

4. Tilea I, Varga A, Serban RC. Past, present, and future of blood biomarkers for the diagnosis of acute myocardial infarction—promises and challenges. Diagnostics 2021;11(5):1–19.

5. Rains MG, Laney CA, Bailey AL, Campbell CL. Biomarkers of acute myocardial infarction in the elderly: Troponin and beyond. Clin Interv Aging 2014;9:1081–90.

6. Eggers KM, Lind L, Ahlström H, Bjerner T, Ebeling Barbier C, Larsson A, et al. Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects. Eur Heart J 2008;29(18):2252–8.

7. Wang B, Li Y, Hao X, Yang J, Han X, Li H, et al. Comparison of the Clinical Value of miRNAs and Conventional Biomarkers in AMI: A Systematic Review. Front Genet 2021;12(June):1–12.

8. Anderson JL M DA. ACUTE MIOCARDIO The New Englad Journal. N Engl J Med 2017;21(367):2053–64.

9. Makki N, Brennan TM, Girotra S. Acute coronary syndrome. J Intensive Care Med 2015;30(4):186–200.

10. Cortez-Dias N, Costa MC, Carrilho-Ferreira P, Silva D, Jorge C, Calisto C, et al. Circulating miR-122-5p/miR-133B ratio is a specific early prognostic biomarker in acute myocardial infarction. Circ J 2016;80(10):2183–91.

11. Badacz R, Kleczy P, Jacek L, Krzysztof Z˙, Jacek G, Przewłocki T, et al. Expression of miR-1-3p, miR-16-5p and miR-122-5p as Possible Risk Factors ofSecondary Cardiovascular Events. Biomedicines 2021;1–12.

12. Dayan N, Schlosser K, Stewart DJ, Okano M, Grand’Maison S, Pilote L. Decreased Circulating Levels of the Lipid-Regulating Mir-122 Are Associated With Prior Preeclampsia in Women With Premature Acute Coronary Syndrome. Can J Cardiol [Internet] 2016;32(10):S109. Available from: http://dx.doi.org/10.1016/j.cjca.2016.07.158

13. Singh S, de Ronde MWJ, Kok MGM, Beijk MA, De Winter RJ, van der Wal AC, et al. MiR-223-3p and miR-122-5p as circulating biomarkers for plaque instability. Open Hear 2020;7(1):e001223.

14. Wang Y, Chang W, Zhang Y, Zhang L, Ding H, Qi H, et al. Circulating miR-22-5p and miR-122-5p are promising novel biomarkers for diagnosis of acute myocardial infarction. J Cell Physiol 2019;234(4):4778–86.

15. Li L, Li S, Wu M, Chi C, Hu D, Cui Y, et al. Early diagnostic value of circulating microRNAs in patients with suspected acute myocardial infarction. J Cell Physiol 2019;234(8):13649–58.

16. Yi J, An Y. Circulating miR-379 as a potential novel biomarker for diagnosis of acute myocardial infarction. Eur Rev Med Pharmacol Sci 2018;22(2):540–6.

Downloads

Published

2024-02-29

How to Cite

Potensi Pemanfaatan Serum Mir 122-5p Sebagai Biomarker Dalam Deteksi Dini Infark Miokard Akut Pada Pasien Lanjut Usia. (2024). JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, 10(2), 14-21. https://doi.org/10.53366/jimki.v10i2.529